Key Metrics: Immunohistochemistry (IHC) Market Share and Size

Rajul123

posted on 3 weeks ago — updated on 1 second ago

29
views

The Immunohistochemistry Market is forecasted to reach $4.08 billion by 2031, growing at a steady CAGR of 7.2% over the period from 2024 to 2031.

Meticulous Research® has recently released a comprehensive report titled Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering, Method, Process, Application, End User—Global Forecast to 2031, which offers a detailed analysis of the immunohistochemistry (IHC) market and its future trajectory.

D Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5967

According to the report, the global IHC market is expected to reach $4.08 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. The primary drivers of this growth include the rising prevalence of chronic diseases, an aging global population, increased awareness around rare diseases, and the growing importance of early diagnosis. Additionally, the market is benefiting from significant R&D investments, a heightened focus on drug discovery and development, and increasing healthcare expenditure worldwide.

Emerging trends, such as the growing inclination towards personalized medicine, ongoing advancements in genomics and proteomics, and the rise in automation across IHC processes, are expected to create new growth opportunities for market players. Nevertheless, challenges like stringent technical requirements, regulatory barriers, and competition from alternative technologies may pose obstacles to market expansion.

Major Players in the Market

Key players identified in the report include global giants like F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and others. These companies are driving innovation and competition within the market through ongoing research, product development, and collaborations.

Market Segmentation Overview

The global IHC market is segmented based on Offering (Consumables, Equipment, Services & Software), Method, Process, Application, and End User.

In 2024, consumables are expected to hold the largest share of the market. Consumables include reagents, kits, and other necessary accessories for IHC testing, which have seen rapid advancement in recent years. These innovations, coupled with the recurring need for these products in clinical settings, have driven significant growth in this segment.

The avidin-biotin complex method is anticipated to dominate the IHC market in terms of methodology in 2024. This method offers several advantages, such as the ability to be labeled with peroxidase, its high affinity for biotin, and its resistance to enzymatic degradation, making it a highly reliable choice for IHC applications.

Clinical applications, particularly in oncology and infectious diseases, are expected to represent the largest portion of the IHC market by 2024. The increasing prevalence of cancer and other chronic diseases, as well as the growing need for early and accurate diagnosis, are key factors driving this trend.

Hospitals and diagnostic laboratories are forecasted to remain the primary end users of IHC solutions due to their significant role in disease diagnosis and treatment. These institutions are increasingly adopting advanced IHC technologies to meet the growing demand for efficient and precise diagnostic tools.

Regional Analysis

In terms of regional growth, the Asia-Pacific region is expected to exhibit the highest CAGR throughout the forecast period. Factors such as the rapid expansion of healthcare infrastructure, increased healthcare investments, and rising awareness about early disease detection in countries like China, India, and Japan are contributing to this growth.

To gain more insights into the market with a detailed table of content and figures, click here:https://www.meticulousresearch.com/product/immunohistochemistry-market-5967

Key questions answered in the report:

Which are the high-growth market segments in terms of offerings, method, application, end user, and region/country?
What was the historical market size for immunohistochemistry globally?
What are the market forecasts and estimates for the period 2024–2031?
What are the major drivers, restraints, challenges, opportunities, and trends in the immunohistochemistry market?
Who are the major players in the global immunohistochemistry market?
What is the competitive landscape like, and who are the market leaders in the global immunohistochemistry market?
What are the recent developments in the global immunohistochemistry market?
What are the different strategies adopted by the major players in the global immunohistochemistry market?
What are the geographical trends and high-growth regions/countries?